The correlation of B7-H3 and HHLA2 expression with clinicopathological features in both cohorts
Variables | Training cohort | Validation cohort | ||||||||||||
Patients no. | B7-H3 expression | HHLA2 expression | Patients no. | B7-H3 expression | HHLA2 expression | |||||||||
Low | High | P value | Low | High | P value | Low | High | P value | Low | High | P value | |||
Age (years) | 0.15 | 0.15 | 0.034 | 0.647 | ||||||||||
<66 | 59 | 25 | 34 | 34 | 25 | 41 | 31 | 10 | 25 | 16 | ||||
≥66 | 67 | 37 | 30 | 30 | 37 | 72 | 40 | 32 | 47 | 25 | ||||
Gleason score | 0.032 | 0.001 | 0.006 | 0.028 | ||||||||||
6–7 (3+4) | 65 | 38 | 27 | 42 | 23 | 54 | 41 | 13 | 40 | 14 | ||||
7 (4+3)–10 | 61 | 24 | 37 | 22 | 39 | 59 | 30 | 19 | 32 | 27 | ||||
Tumor stage | 0.006 | 0.049 | 0.001 | 0.031 | ||||||||||
T2 | 76 | 45 | 31 | 44 | 32 | 80 | 58 | 22 | 56 | 24 | ||||
T3–4 | 50 | 17 | 33 | 20 | 30 | 33 | 13 | 20 | 16 | 17 | ||||
Nodal metastasis | 0.001 | 0.002 | 1 | 0.046 | ||||||||||
Absent | 108 | 60 | 57 | 61 | 47 | 110 | 69 | 41 | 72 | 38 | ||||
Present | 18 | 2 | 7 | 3 | 15 | 3 | 2 | 1 | 0 | 3 | ||||
Distal metastasis | 0.324 | 0.052 | 0.145 | 0.709 | ||||||||||
Absent | 116 | 59 | 52 | 62 | 54 | 105 | 68 | 37 | 66 | 39 | ||||
Present | 10 | 3 | 39 | 2 | 8 | 8 | 3 | 5 | 6 | 2 | ||||
B7-H3 expression | – | 0.002 | – | 0.02 | ||||||||||
Low | 62 | – | – | 40 | 22 | 71 | – | – | 51 | 20 | ||||
High | 64 | – | – | 24 | 40 | 42 | – | – | 21 | 21 |
P values <0.05 marked in bold font are statistically significant.